Methicillin-Resistant Staphylococcus aureus

New England Journal of Medicine

Volumn 320, Issue 18, 1989, Pages 1188-1196

  Brumfitt, William ^a   Hamilton Miller, Jeremy ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CLINDAMYCIN; COUMAMYCIN; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; METICILLIN; NOVOBIOCIN; PRISTINAMYCIN; QUINOLONE DERIVATIVE; RIFAMPICIN; SULFONAMIDE; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS;

EID: 0024604271     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198905043201806     Document Type: Review

References (120)

1. Finland M. Recapitulation and discussion. In.: Welch M, Finland M, eds. Therapy for staphylococcal diseases. New York.: Medical Encyclopedia, 1959.:187-200.
2. Barber M, Rozwadowska-Dowzenko M. Infection by penicillin-resistant staphylococci. Lancet 1948; 2.: 641-4.
3. Rolinson GN, Stevens S, Batchelor FR, Wood JC, Chain EB. Bacteriological studies on a new penicillin - BRL.1241. Lancet 1960; 2.: 564-7.
4. Sheagren JN. Staphylococcus aureus.: the persistent pathogen. N Engl J Med 1984; 310.: 1368-73, 1437-42.
5. Jevons MP. “Celbenin”-resistant staphylococci. Br Med J 1961; 1.: 124-5.
6. Knox R. Celbenin'-resistant staphylococci. Br Med J 1961; 1.: 126.
7. Methicillin-resistant Staphylococcus aureus. Med J Aust 1982; 1.: 445-88.
8. Frongillo RF, Donati L, Federico G, et al. Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother 1986; 29.: 789-96.
9. National Committee for Clinical Laboratory Standards. Approved standard.: performance standards for antimicrobial disk susceptibility tests (M2-A3). 3rd ed. Villanova, Pa.: National Committee for Clinical Laboratory Standards, 1984.
10. Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits.: expression of resistance to I-lactam antibiotics in vivo and in vitro. J Infect Dis 1984; 149.: 894-903.
11. Kline MW, Mason EO Jr, Kaplan SL. Outcome of heteroresistant Staphylococcus aureus infections in children. J Infect Dis 1987; 156.: 205-8.
12. Boyce JM, Medeiros AA, Rimland D. Detection and treatment of infections caused by Staphylococcus aureus resistant to penicillinase-resistant penicillins. J Infect Dis 1988; 157.: 602-5.
13. Sabath LD, Wallace SJ. Factors influencing methicillin resistance in staphylococci. Ann NY Acad Sci 1971; 182.: 258-66.
14. de Rautlin de la Roy Y, FanaudP, Grignon B. Le problme de la sensibilite in vitro au cefamandole de Staphylococcus aureus rasistants lamthicilline. Pathol Biol (Paris) 1985; 33.: 957-61.
15. Frongillo RF, Bianchi P, Moretti A, Pasticci MB, Ripa S, Pauluzzi S. Cross-resistance between methicillin and cephalosporins for staphylococci.: a general assumption not true for cefamandole. Antimicrob Agents Chemother 1984; 25.: 666-8.
16. Traub WH, Spohr M. Bauer D. Gentamicin- and methicillin-resistant, clinical isolates of Staphylococcus aureus.: comparative in vitro and in vivo efficacy of alternative antimicrobial drugs. Chemotherapy 1984; 30.: 102-12.
17. Boyce JM. Re-evaluation of the ability of the standardized disk diffusion test to detect methicillin-resistant strains of Staphylococcus aureus. J Clin Microbiol 1984; 19.: 813-7.
18. El Hagarawy N, Lenz W, Elkhouly A, El Molla AH. The importance of incubation temperature for detecting beta-lactam-resistant Staphylococcus aureus strains. Infection 1982; 10.: 371-4.
19. Alvarez S, Jones M, Berk SL. In vitro activity of fosfomycin, alone and in combination, against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1985; 28.: 689-90.
20. Hirschl A, Stanek G, Rotter M. Effectiveness of cefamandole against methicillin-resistant strains of Staphylococcus aureus in vitro and in experimental infections. J Antimicrob Chemother 1984; 13.: 429-35.
21. Fan W, del Busto R, Love M, et al. Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother 1986; 29.: 26-9.
22. Forbes BA, McClatchey KD, Schaberg DR. Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1984; 25.: 491-3.
23. Crossley K, Loesch D, Landesman B, Mead K, Chern M, Strate R. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. I. Clinical studies. J Infect Dis 1979; 139.: 273-9.
24. Rimland D. Nosocomial infections with methicillin and tobramycin resistant Staphylococcus aureus - implication of physiotherapy in hospitalwide dissemination. Am J Med Sci 1985; 290.: 91-7.
25. Cafferkey MT, Hone R, Keane CT. Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1985; 28.: 819-23.
26. Klastersky J, Hensgens C, Daneau D. Therapy of staphylococcal infections.: (a comparative study of cephaloridine and gentamicin). Am J Med Sci 1975; 269.: 201-7.
27. Watanakunakorn C, Glotzbecker C. Enhancement of the effects of antistaphylococcal antibiotics by aminoglycosides. Antimicrob Agents Chemother 1974; 6.: 802-6.
28. Sande MA, Courtney KB. Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med 1976; 88.: 118-24.
29. Korzeniowski O, Sande MA, National Collaborative Endocarditis Study Group. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts.: a prospective study. Ann Intern Med 1982; 97.: 496-503.
30. Coppens L, Hanson B, Klastersky J. Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin. Antimicrob Agents Chemother 1983; 23.: 36-41.
31. Markowitz N, Saravolatz L, Pohlod D, et al. Comparative efficacy and toxicity of trimethoprim-sulfamethoxazole (TS) vs vancomycin (V) in the therapy of S. aureus (Sa) infection. Presented at the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis, September 29-October 2, 1985. abstract.
32. Elwell LP, Wilson HR, Knick VB, Keith BR. In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1986; 29.: 1092-4.
33. Smith SM, Mangia A, Eng RH, Ruggeri P, Cytryn A, Tecson-Tumang F. Clindamycin for colonization and infection by methicillin-resistant Staphylococcus aureus. Infection 1988; 16.: 95-7.
34. Schaefler S, Jones D, Perry W, et al. Emergence of gentamicin- and methicillin-resistant Staphylococcus aureus strains in New York City hospitals. J Clin Microbiol 1981; 13.: 754-9.
35. Craven DE, Reed C, Kollisch N, et al. A large outbreak of infections caused by a strain of Staphylococcus aureus resistant to oxacillin and aminoglycosides. Am J Med 1981; 71.: 53-8.
36. Peacock JE Jr, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus.: introduction and spread within a hospital. Ann Intern Med 1980; 93.: 526-32.
37. Locksley R.M. Cohen M.L., Quinn T.C., et al. Multiply antibiotic-resistant Staphylococcus aureus.: introduction, transmission, and evolution of nosocomial infection. Ann Intern Med 1982; 97.: 317-24.
38. Cafferkey MT, Hone R, Coleman D, et al. Methicillin-resistant Staphylococcus aureus in Dublin 1971-84. Lancet 1985; 2.: 705-8.
39. Williams JD, Phillips I, eds. Rifampicin as an anti-staphylococcal agent. Antimicrob Chemother 1984; 13.: Suppl C.: 1-68.
40. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987; 316.: 927-31.
41. Craven DE, Kollisch NR, Hsieh CR, Connolly MG Jr, McCabe WR. Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus.: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis 1983; 147.: 137-43.
42. Williams AH, Gruneberg RN. Teicoplanin. J Antimicrob Chemother 1984; 14.: 441-5.
43. Neu HC, Chin NX, Labthavikul P. Antibacterial activity of coumermycin alone and in combination with other antibiotics. Antimicrob Agents Chemother 1984; 25.: 687-9.
44. Meyers BR, Srulevitch ES, Hirschman SZ. Comparative in vitro activity of coumermycin against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1985; 28.: 706-7.
45. Wolfson JS, Hooper DC The fluoroquinolones.: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 1985; 28.: 581-6.
46. Lau WY, Teoh-Chan CH, Fan ST, Lau KF. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia. J Hyg 1986; 96.: 419-23.
47. Baron D, Drugeon H, Courtieu AL, Nicolas F. SepticAmies et infections graves germes multirAsistants.: rAsultats du traitment par la fosfomycine. Med Mal Infect 1981; 11.: 255-61.
48. Dureux JB, Canton P, Weber M, Toussain P, Roche G. La fosfomycine dans le traitment des Atats septicAmiques et des endocardites bactAriennes. Med Mal Infect 1981; 11.: 524-32.
49. Fosse T, David MF, Dulac F, Darmusey D, Tamalet C, Toga B. Etude in vitro de l'association cAfamandole-fosfomycine vis--vis de souches cliniques de staphylocoques mAthicilline-rAsistants. Pathol Biol (Paris) 1984; 32.: 528-31.
50. Thabaut A. Meyran M, Huerre M. Evolution and present situation of Staphylococcus aureus sensitivity to MLS in hospital (1975-83). J Antimicrob Chemother 1985; 16.: Suppl A.: 205-7.
51. Petit JC, Cohen F, Couchoud S, Daguet GL. Staphylococcus aureus oxacilline et gentamicine-rAsistants.: survenue et Avolution sur une pAriode de 6 mois. Biomed Pharmacother 1983; 37.: 429-33.
52. Duval J. Evolution and epidemiology of MLS resistance. J Antimicrob Chemother 1985; 16.: Suppl A.: 137-49.
53. Gibert C, Domart Y, Chastre J. pathologic intra-hospitalire due aux staphylocoques rasistants lamaticilline. Presse Med 1985; 14.: 2081-3.
54. Brumfitt W, Hamilton-Miller JMT, Whiter G. Paldimycin.: a novel antibiotic highly active against gram-positive bacteria. J Antimicrob Chemother 1987; 19.: 405-6.
55. Benson CA, Beaudette F, Trenholm G. Comparative in vitro activity of LY146032, a new peptolide, with vancomycin and eight other agents against gram-positive organisms. J Antimicrob Chemother 1987; 20.: 191-6.
56. Kephart PA, Esposito AL. Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1988; 21.: 33-9.
57. Lyon BR, Skurray R. Antimicrobial resistance of Staphylococcus aureus.: genetic basis. Microbiol Rev 1987; 51.: 88-134.
58. Brumfitt W, Dixson S, Hamilton-Miller JMT. Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus. Lancet 1985; 1.: 1442-3.
59. Malouin F, Bryan LE. Modification of penicillin-binding proteins as mechanisms of lactam resistance. Antimicrob Agents Chemother 1986; 30.: 1-5.
60. Madiraju MV, Brunner DP, Wilkinson BJ. Effects of temperature. NaCl, and methicillin on penicillin-binding proteins, growth, peptidoglycan synthesis, and autolysis in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1987; 31.: 1727-33.
61. McDougal LK, Thomsberry C. The role of lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol 1986; 23.: 832-9.
62. Dyke KGH. Penicillinase production and intrinsic resistance to penicillins in methicillin-resistant cultures of Staphylococcus aureus. J Med Microbiol 1969; 2.: 261-78.
63. Eng RH, Smith SM, Tillem M, Cherubin C. Rifampin resistance.: development during the therapy of methicillin-resistant Staphylococcus aureus infection. Arch Intern Med 1985; 145.: 146-8.
64. Archer GL, Mayhall CG. Comparison of epidemiological markers used in the investigation of an outbreak of methicillin-resistant Staphylococcus aureus infections. J Clin Microbiol 1983; 18.: 395-9.
65. McDonnell RW, Sweeney HM, Cohen S. Conjugational transfer of gentamicin resistance plasmids intra- and interspecifically in Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 1983; 23.: 151-60.
66. Forbes BA, Schaberg DR. Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus.: evidence for conjugative exchange of resistance. J Bacteriol 1983; 153.: 627-34.
67. Cohen ML, Wong ES, Falkow S. Common R-plasmids in Staphylococcus aureus and Staphylococcus epidermidis during a nosocomial Staphylococcus aureus outbreak. Antimicrob Agents Chemother 1982; 21.: 210-5.
68. Townsend DE, Ashdown N, Grubb WB. Evolution of Australian isolates of methicillin-resistant Staphylococcus aureus.: a problem of plasmid incompatibility? J Med Microbiol 1985; 20.: 49-61.
69. Thomsberry C, McDougal LK. Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci. J Clin Microbiol 1983; 18.: 1084-91.
70. Lally RT, Ederer MN, Woolfrey BF. Evaluation of mannitol salt agar with oxacillin as a screening medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1985; 22.: 501-4.
71. Hansen SL, Pope WA. Screening method for rapid detection of methicillin-resistant (heteroresistant) Staphylococcus aureus. J Clin Microbiol 1985; 22.: 886-7.
72. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus.: report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy. J Hosp Infect 1986; 7.: 193-201.
73. Milne LM, Curtis GD, Crow M, Kraak WA, Selkon JB. Comparison of culture media for detecting methicillin resistance in Staphylococcus aureus and coagulase negative staphylococci. J Clin Pathol 1987; 40.: 1178-81.
74. French GL, Ling JL, Hui Y-W, Oo HK. Determination of methicillin-resistance in Staphylococcus aureus by agar dilution and disc diffusion methods. J Antimicrob Chemother 1987; 20.: 599-608.
75. Hindier JA, Inderlied CB. Effect of the source of Mueller-Hinton agar and resistance frequency on the detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1985; 21.: 205-10.
76. Annear DI. Methicillin-resistant Staphylococcus aureus. Med J Aust 1984; 140.: 144-5.
77. Pearman JW, Christiansen KJ, Annear DI, et al. Control of methicillin-resistant Staphylococcus aureus (MRSA) in an Australian metropolitan teaching hospital complex. Med J Aust 1985; 142.: 103-8.
78. Aldridge KE, Janney A, Sanders CV, Robert L. Interlaboratory variation of antibiograms of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains with conventional and commercial testing systems. J Clin Microbiol 1983; 18.: 1226-36.
79. Jones RN, Edson DC. Special topics in antimicrobial susceptibility testing.: test accuracy against methicillin-resistant Staphylococcus aureus, pneumococci, and the sensitivity of lactamase methods. Am J Clin Pathol 1983; 80.: 609-14.
80. Hansen SL, Freedy PK. Variation in the abilities of automated, commercial, and reference methods to detect methicillin-resistant (heteroresistant) Staphylococcus aureus. J Clin Microbiol 1984; 20.: 494-9.
81. Barton AP. A rapid bioluminescent method for the detection of methicillinresistant Staphylococcus aureus colonies. J Antimicrob Chemother 1985; 15.: 61-7.
82. Hill AW, James AM. Surface properties of cells of methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus grown at 37C. Microbios 1972; 6.: 157-67.
83. Espersen F, Nielsen PB, Lund K, Sylvest B, Jensen K. Hospital-acquired infections in a burns unit caused by an imported strain of Staphylococcus aureus with unusual multi-resistance. J Hyg 1982; 88.: 535-41.
84. Schaefler S, Jones D, Perry W, Baradet T, Mayr E, Rampersad C. Methicillin-resistant Staphylococcus aureus strains in New York City hospitals.: inter-hospital spread of resistant strains of type 88. J Clin Microbiol 1984; 21.: 536-8.
85. Saravolatz LD, Pohlod DJ, Arking LM. Community-acquired methicillin-resistant Staphylococcus aureus infections.: a new source for nosocomial outbreaks. Ann Intern Med 1982; 97.: 325-9.
86. Bartzokas CA, Paton JH, Gibson MF, Graham R, McLoughlin GA, Croton RS. Control and eradication of methicillin-resistant Staphylococcus aureus on a surgical unit. N Engl J Med 1984; 311.: 1422-5.
87. Melo Cristino JA, Pereira AT, Afonso F, Naidoo JN. Methicillin-resistant Staphylococcus aureus.: a 6-month survey in a Lisbon paediatric hospital. J Hyg 1986; 97.: 265-72.
88. Fournier JM, Bouvet A, Boutonnier A, et al. Predominance of capsular polysaccharide type 5 among oxacillin-resistant Staphylococcus aureus. J Clin Microbiol 1987; 25.: 1932-3.
89. Stephenson JR, Crook SJ, Tabaqchali S. New method for typing Staphylococcus aureus resistant to methicillin based on sulphur-35 methionine labeled proteins.: its application in an outbreak. Br Med J 1986; 293.: 581-3.
90. Pessione E, Giunta C. Enzymatic characterization of Staphylococcus aureus strains.: a possible role of habitat and methicillin resistance in the determination of the differences observed. Microbios 1986; 47.: 107-12.
91. Roberts JI, Gaston MA. Protein A and coagulase expression in epidemic and non-epidemic Staphylococcus aureus. J Clin Pathol 1987; 40.: 837-40.
92. Craven DE, Rixinger Al, Goularte TA, McCabe WR. Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a “shooting gallery.” Am J Med 1986; 80.: 770-6.
93. Levine DP, Cushing RD, Jui J, Brown WJ. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med 1982; 97.: 330-8.
94. Haley RW, Hightower AW, Khabbaz RF, et al. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals.: possible roles of the house staff-patient transfer circuit. Ann Intem Med 1982; 97.: 297-308.
95. Winn RE, Ward TT, Hartstein AI, et al. Epidemiological, bacteriological, and clinical observations on an interhospital outbreak of nafcillin-resistant Staphylococcus aureus. In.: Nelson JD, Grassi C, eds. Current chemotherapy and infectious disease. Vol. II. Washington, D.C.: American Society for Microbiology, 1980.:1096-7.
96. Shanson DC, McSwiggan DA. Operating theatre acquired infection with a gentamicin-resistant strain of Staphylococcus aureus.: outbreaks in two hospitals attributable to one surgeon. J Hosp Infect 1980; 1.: 171-2.
97. Saravolatz LD, Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin-resistant Staphylococcus aureus.: epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982; 96.: 11-6.
98. Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intem Med 1982; 97.: 309-17.
99. Crossley K, Landesman B, Zaske D. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. II. Epidemiological studies. J Infect Dis 1979; 139.: 280-7.
100. Linnemann CC Jr, Mason M, Moore P, Korfhagen TR, Staneck JL. Methicillin-resistant Staphylococcus aureus.: experience in a general hospital over four years. Am J Epidemiol 1982; 115.: 941-50.
101. Ballou WR, Cross AS, Williams DY, Keiser J, Zierdt CH. Colonization of newly arrived house staff by virulent staphylococcal phage types endemic to a hospital environment. J Clin Microbiol 1986; 23.: 1030-3.
102. Casewell MW, Hill RL. The carrier state.: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1986; 18.: Suppl A.: 1-12.
103. Centers for Disease Control. Isolation techniques for use in hospitals. 2nd ed. Washington D.C.: Government Printing Office, 1975. (PHS publication no. DHEW-CDC-76-8314.)
104. Committee on Fetus and Newborn. Control of infection in standards and recommendations for hospital care of new-born infants. Evanston, 111.: American Academy of Pediatrics, 1977.:109-29.
105. Pavillard R, Harvey K, Douglas D, et al. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals. Med J Aust 1982; 1.: 451-4.
106. Selkon JB, Stokes ER, Ingham HR. The role of an isolation unit in the control of hospital infection with methicillin-resistant staphylococci. J Hosp Infect 1980; 1.: 41-6.
107. Sanderson PJ. Staying one jump ahead of resistant Staphylococcus aureus. Br Med J 1986; 293.: 573-4.
108. Dacre J, Emmerson AM, Jenner EA. Gentamicin-methicillin-resistant Staphylococcus aureus.: epidemiology and containment of an outbreak. J Hosp Infect 1986; 7.: 130-6.
109. Bell SM. Recommendations for control of the spread of methicillin-resistant Staphylococcus aureus infection.: based on 18 years' experience in a group of teaching hospitals. Med J Aust 1982; 1.: 472-4.
110. Lejeune B, Buzit-Losquin F, Simitzis-Le Flohic AM, Le Bras MP, Alix D. Outbreak of gentamicin-methicillin-resistant Staphylococcus aureus infection in an intensive care unit for children. J Hosp Infect 1986; 7.: 21-5.
111. Graham DR, Correa-Villasenor A, Anderson RL, Vollman JH, Baine WB. Epidemic neonatal gentamicin-methicillin-resistant Staphylococcus aureus infection associated with nonspecific topical use of gentamicin. J Pediatr 1980; 97.: 972-8.
112. Boyce JM, White RL, Causey WA, Lockwood WR. Burn units as a source of methicillin-resistant Staphylococcus aureus infections. JAMA 1983; 249.: 2803-7.
113. Dunkle LM, Naqvi SH, McCallum R, Lofgren JP. Eradication of epidemic methicillin-gentamicin-resistant Staphylococcus aureus in an intensive care nursery. Am J Med 1981; 70.: 455-8.
114. Bradley JM, Noone P, Townsend DE, Grubb WB. Methicillin-resistant Staphylococcus aureus in a London hospital. Lancet 1985; 1.: 1493-5.
115. Aeilts GD, SapicoFL, Canawati HN, Malik GM, MontgomerieJZ. Methicillin-resistant Staphylococcus aureus colonization and infection in a rehabilitation facility. J Clin Microbiol 1982; 16.: 218-23.
116. Tyzack R. The management of methicillin-resistant Staphylococcus aureus in a major hospital. J Hosp Infect 1985; 6.: Suppl A.: 195-9.
117. Bannister BA. Management of patients with epidemic methicillin-resistant Staphylococcus aureus.: experience at an infectious diseases unit. J Hosp Infect 1987; 9.: 126-31.
118. Rahman M, Noble WC, Cookson B. Mupirocin-resistant Staphylococcus aureus. Lancet 1987; 2.: 387.
119. Baird D, Coia J. Mupirocin-resistant Staphylococcus aureus. Lancet 1987; 2.: 387-8.
120. Smith GE, Kennedy CT. Staphylococcus aureus resistant to mupirocin. J Antimicrob Chemother 1988; 21.: 141-2.